Urology

Urology Devices- Market Insights, Competitive Landscape and Market Forecast–2027

Wed, 27 Apr 2022 14:02:44 +0000

Urology Devices Market By Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, And Others], Uroodynamic Systems, Lithotripters, Biopsy Devices, Uretral Stents, And Others), By End User (Hospitals, Specialty Clinics, And Others), And by geography is expected to grow at an appreciable CAGR forecast till 2027 owing to rising prevalence of urogenital disorders such as kidney stones and cancers of urogenital system. Global urology devices market was valued at USD 9.17 billion in 2021, growing at a CAGR of 6.78% during the forecast period from 2022 to 2027 to reach USD 13.56 billion by 2027. The urology devices market is witnessing an explosion in product demand due to numerous reasons such as increasing geriatric population who make up for a formidable share of the total population susceptible to developing various age-related indications such as benign prostatic hyperplasia in older men, increasing prevalence of kidney disorders such as kidney stones, growing prevalence of lifestyle disorders such as hypertension and diabetes that may impact the hea...

$4,750.00

Urology Lasers - Market Insights, Competitive Landscape and Market Forecast–2026

Mon, 31 May 2021 11:41:14 +0000

DelveInsight’s ‘Urology Lasers - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Urology Lasers and the historical and forecasted Urology Lasers market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan. The Urology Lasers market report provides an overview of Urology Lasers, applications of Urology Lasers as well as its PEST Analysis. Additionally, the report provides insight on the Urology Lasers market share of the individual Urology Lasers, current and forecasted Urology Lasers market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market. Urology Lasers Overview Laser energy has become the most commonly used modality for treatment of urinary tract calculi and is increasingly being used for soft tissue applications such as prostate ablation. Development of medical lasers has had a revolutionary impact...

$4,750.00

Urology Ultrasounds Devices Market Insights, Competitive Landscape and Market Forecast–2025

Fri, 05 Feb 2021 15:36:57 +0000

DelveInsight’s ‘Urology Ultrasounds Devices -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Urology Ultrasounds Devices and the historical and forecasted Urology Ultrasounds Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. The Urology Ultrasounds Devices market report provides an overview of Urology Ultrasounds Devices , reasons to get Urology Ultrasounds Devices as well as its advantages and limitations. Additionally, the report provides insight on the Urology Ultrasounds Devices market share of the individual Urology Ultrasounds Devices devices, current and forecasted Urology Ultrasounds Devices market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market. Urology Ultrasounds Devices Overview Anatomies such as the prostate, bladder, and kidney are viewed by urological ultrasounds. These...

$4,750.00

South Asia Flexible Endoscope Market by Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro Endoscopy, Gastrointestinal Endoscopy, Obstetrics/Gynecology Endoscopy, ENT Endoscopy, and Others) and End User

Fri, 26 Jul 2019 11:44:09 +0000

Endoscopy is a minimally invasive medical procedure used for diagnosis, prevention, and treatment of complications in visceral organs. The device is either placed in the body through natural openings or cavities (such as anus and mouth) or through incisions, especially in case of arthroscopy. The South Asia flexible endoscope market was valued at $284 million in 2017, and is anticipated to reach $510 million by 2025, registering a CAGR of 7.4%. Flexible endoscopy devices are equipped with several other parts such as camera or light source at the tip of endoscopes that help physicians or medical professionals to analyze the internal organs of interest. Endoscopy is used to evaluate various conditions such as stomach pain, ulcers, gastritis, digestive tract bleeding, cancerous growth in colon, and changes in bowel habits. Moreover, it is categorized based on the area of the body that are investigated. This includes knee & joints (arthroscopy), lungs (bronchoscopy), colon (colonoscopy), abdominal & pelvic areas (laparoscopy), and others. Increase in the incident rate of targeted dise...

$3,000.00

Urology Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

Tue, 25 Feb 2020 15:44:53 +0000

The market for urinary incontinence treatments includes urinary catheters and incontinence management devices. The urinary catheter market is segmented into intermittent, Foley and male external catheters. The total incontinence management implantable device market is segmented into female incontinence slings and male implantable devices. The former is further sub-segmented into transvaginal tape, transobturator and single-incision slings. Male implantable devices include male incontinence slings and male artificial urinary sphincters....

$8,995.00

Urology Market Analysis, Size, Trends | Brazil | 2020-2026 | MedSuite (Includes 6 Reports)

Tue, 25 Feb 2020 15:44:53 +0000

The healthcare system in Japan was established as the universal health insurance scheme in 1961, according to which citizens can access medical services for a relatively low co-payment. Over the last decades, the rapidly-growing aging population combined with the decrease in the working population have caused financial difficulty. These also resulted in structural reform in healthcare, due to higher prevalence of chronic and age-related conditions....

$8,995.00

Urology Market Analysis, Size, Trends | Australia | 2020-2026 | MedSuite (Includes 6 Reports)

Tue, 25 Feb 2020 15:44:53 +0000

The BPH treatment market and the stone management device market accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases and the premium prices for lasers and lithotripters....

$8,995.00

Urology Market Analysis, Size, Trends | Brazil | 2020-2026 | MedSuite (Includes 6 Reports)

Tue, 25 Feb 2020 15:44:53 +0000

BPH is prevalent among men over the age of 50 years. Prevalence increases with age, reaching figures of 85% to 90% for men above the age of 80. Brazil is aging at record highs. By 2050, Brazil will have around 66 million people above the age 60 living in its territory, or three times more than the 24 million today...

$8,995.00

Urology Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

Tue, 25 Feb 2020 15:39:53 +0000

$8,995.00

Urological Devices Market Report Suite | United States | 2019-2025| MedSuite (Includes 10 Reports)

Wed, 13 Nov 2019 13:39:22 +0000

...

$10,995.00

Urological Devices Market Report Suite | Europe | 2019-2025| MedSuite

Wed, 13 Nov 2019 13:39:22 +0000

...

$13,995.00

Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 20

Fri, 26 Jul 2019 11:45:30 +0000

“The global inflation devices market is projected to grow at a CAGR of 4.7% during the forecast period” The global inflation devices market is projected to reach USD 600 Million by 2024 from USD 480 Million in 2019, at a CAGR of 4.7% from 2019 to 2024. The increasing incidence of target diseases, favorable medical reimbursement for minimally invasive procedures in developed countries, rising demand of minimally invasive surgical procedures across major countries, and increasing applications of inflation devices are the key factors driving the growth of inflation devices market. Government initiatives to control the burden of healthcare-associated infections (HAI) in developed countries and increasing healthcare expenditure across emerging markets are further assisting market growth. “The analog inflation devices segment accounted for the largest market share of global inflation devices market in 2018” Based on display type, the inflation devices market is segmented into analog and digital display inflation devices. The analog display inflation devices segment is expected to ...

$5,650.00

Vascular Guidewires Market by Application (Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires), Coating Type (Coated, and Non-Coated), and End User (Hospitals and Ambulatory Surgical Centers)

Fri, 26 Jul 2019 11:44:09 +0000

The global vascular guidewires market size in 2017 is $883 million, and is projected to reach $1,336 million by 2025, growing at a CAGR of 5.4% from 2018 to 2025. A guidewire is a long and flexible spring that assists the introduction and placement of implantable medical devices into a patient’s body. Vascular guidewires are used during various interventional cardiology procedures (including placement of angioplasty balloons, stents, inferior vena cava filters, and others) as they guide a surgeon for the correct placement of these devices. There is an increase in the demand for vascular guidewires due to rise in the prevalence of cardiovascular disorders, increase in geriatric population, demand for minimally invasive procedures, and rapid technological advancements in guidewires drive the market growth. However, risks and complications associated with guidewires, and availability of effective conventional treatment options restrict the market growth. Conversely, increase in use of nitinol in vascular guidewires and growth opportunities in the emerging economies of the Asia-Pacif...

$5,370.00

European Market Report for Urological Endoscopes 2016 - MedCore

Thu, 16 Feb 2017 10:40:07 +0000

The urological endoscope market comprises rigid and flexible cystoscopes, semi-rigid and flexible ureteroscopes, rigid resectoscopes and rigid nephroscopes. This report includes the sales of new endoscopes only and does not discuss the sales of refurbished or repaired units. The total cystoscope market represented the largest portion of the total endoscope market. Endoscope market growth rates are linked to procedural volumes, which in turn are driven by the aging population as well as the growing incidence of diseases such as urinary stones and cancer. Urological endoscopes are long, tube-like instruments used in a number of urological procedures to examine inside the body or perform minimally invasive surgery. Urological endoscopes include cystoscopes for endoscopy of the urinary bladder, ureteroscopes for examining the ureter, resectoscopes used in transurethral resection of the prostate (TURP) and nephroscopes used to examine the kidneys....

$6,495.00

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

Thu, 15 Sep 2016 20:01:35 +0000

Summary

Urological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer – the key indications covered in this report – accounting for the majority of that figure. Urological cancers affect the male and female urinary tract and the male reproductive organs. Prostate cancer is the most prevalent of these malignancies.

A number of common etiologic factors have been strongly characterized as raising the risk of developing urological cancers, including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. The risk of cancer increases greatly in patients over the age of 65. Populations in developed countries are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and revenue growth for its treatments.

Hormone therapies for prostate cancers and angiogenesis inhibitors for renal cell carcinoma are currently the most commercially successful urological cancer drugs. However, there has been a shi...

$4,995.00